Open Access“Double Hit” in Chronic Lymphocytic Leukemia: Therapeutic Strategies for Patients with 17p Deletion and TP53 Mutation
Author(s) -
Daniel Ezekwudo,
Tolulope Ifabiyi,
Angela Usim,
Ishmael Jaiyesimi
Publication year - 2019
Publication title -
journal of cancer science and clinical therapeutics
Language(s) - English
Resource type - Journals
ISSN - 2637-5079
DOI - 10.26502/jcsct.5079019
Subject(s) - bruton's tyrosine kinase , chronic lymphocytic leukemia , oncology , cancer research , tyrosine kinase , medicine , cd19 , ibrutinib , mutation , targeted therapy , philadelphia chromosome , leukemia , biology , immunology , cancer , antigen , genetics , chromosomal translocation , gene , receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom